Adverse events of raltegravir and dolutegravir

OBJECTIVE: To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN: Prospective cohort study. METHODS: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AIDS
Auteurs principaux: Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2017
Sujets:
Clinical Science: Concise Communications
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566167/
https://ncbi.nlm.nih.gov/pubmed/28692533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001590
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires